July 24, 2026

Judge Rules Biden-Era Mifepristone Restrictions Unlawful

U.S. District Judge Robert S. Ballou ruled that the FDA's 2023 requirements for mifepristone prescriptions were unjustified and unlawful.
The ruling mandates the FDA to reconsider these restrictions, which have been criticized as arbitrary.
Mifepristone remains a critical medication, accounting for over 60% of abortions in the U.S., amid ongoing legal and political battles over its access.